Main

When it was first described in 1963, the 18p− syndrome was the only autosomal deletion syndrome then known to be compatible with long-term survival.1 Reported clinical features include speech delay, growth hormone deficiency,2 cardiac anomalies,3 ptosis, and holoprosencephaly.4 Mental retardation has also been associated with this syndrome, but this phenotype has wide variation, ranging from severe mental retardation to borderline normal intelligence.5,6

We are interested in understanding the molecular basis of the clinical characteristics in this syndrome. Detailed molecular analyses were used to ascertain the size and parental origin of the deletion in each subject. Determining the exact size of the deletion is necessary for identifying critical regions and candidate genes that may contribute to a phenotype. Identification of critical regions, using molecular and cytogenetic methods, has already been done for other aneusomies such as Turner syndrome,7 Down syndrome,8 cri-du-chat (5p-) syndrome,9 and 18q− syndrome.10,11

It is important to know the parental origin of the chromosome with the deletion for two reasons. First, there can be differences in the origin of the deletion, dependent on the sex of the parent. Parental origin biases in mutation rates were reviewed by Chandley.12 Chromosome abnormalities in particular have exhibited parent-of-origin biases. Abnormalities resulting from nondisjunction, such as trisomies 18 and 21, have a maternal parent of origin tendency,1315 whereas structural rearrangements such as terminal deletions have an increased paternal origin bias.16 Developmental differences between oogenesis and spermatogenesis may give rise to a parent of origin bias in individuals with chromosomal abnormalities. The paternal bias in structural rearrangements is thought to be due to the greater number of cell divisions during male meiosis, as well as minimal repair capacity in sperm.12

Second, the parental origin of a deleted chromosome can also have an effect on phenotypic outcome, a process known as imprinting. The most commonly cited example is the microdeletion 15q11-q13. If the microdeletion is maternally derived or there is paternal uniparental disomy of chromosome 15, the child will have Angelman syndrome. If the 15q11-q13 microdeletion is paternally derived or there is maternal uniparental disomy, the child will have Prader-Willi syndrome.17 As this project is part of a larger genotype/phenotype correlation study of the 18p− syndrome, we wanted to determine the parental origin of the deletion to look for parental age and imprinting effects.

Our results describe the molecular analyses of the largest group of 18p− patients in a single study. We demonstrate the presence of a possible breakpoint cluster on the short arm of chromosome 18 and the absence of a parent-of-origin bias for terminal de novo deletions, regardless of where on the chromosome the deletion occurs. We also show a statistically significant difference in average maternal age between those deletions in the putative breakpoint cluster and those that are not in the breakpoint cluster region.

Subjects and Methods

Patients

Twenty-five subjects with deletions of 18p were recruited from The Chromosome 18 Registry and Research Society. Written informed consent was obtained for all subjects under an institutional review board-approved protocol. The 25 unrelated subjects provided medical records and blood samples. If cytogenetic reports were not available, the proband and parental karyotypes were repeated by our laboratory with G-banding analysis of at least a 550-band level. All individuals with 18p deletions that were the result of inherited unbalanced translocations or other rearrangements were excluded from the analysis. Only nonmosaic patients with de novo deletions of 18p were included in the study.

Microsatellite analysis

Genomic DNA was isolated from whole blood using the PUREGENE DNA Isolation kit (Gentra Systems; Minneapolis, MN). Molecular analysis of the deletions was completed by PCR with polymorphic microsatellite primers. All markers used were from Généthon18 with the exception of D18S852 (Cooperative Human Linkage Center) and D18S40.19 Initially, the microsatellite markers chosen were evenly distributed on 18p. After the apparent breakpoint cluster was identified, additional microsatellite markers were selected from the pericentromeric region to further define the location of the breakage site.

Reaction conditions were 50 ng template DNA, 50 ng of each primer, 1.5 mM MgCl2, 50 mM KCl, 200 μM dNTPs, and 1 U of Taq polymerase (Applied Biosystems, Inc., Foster City, CA). The forward primer was end-labeled with 0.5 μCi [γ-32P]ATP using 0.4 U of T4 polynucleotide kinase. An initial denaturation step of 5 minutes at 94°C was followed by 35 cycles of 1 minute at 94°C, 1 minute at an average annealing temperature of 55°C, and 1 minute at 72°C, with a final extension at 72°C for 10 minutes. Annealing temperatures for each set of primers ranged from 50 to 65°C depending on the GC content of the primers. Products were electrophoresed on a 7% acrylamide gel.

Fluorescence in situ hybridization

In cases where markers in the pericentromeric region were uninformative, fluorescence in situ hybridization (FISH) was performed to determine the approximate boundaries of the breakpoint cluster. An alpha satellite probe (Vysis, Inc., Downers Grove, IL) was used to confirm the presence of the centromere when D18S1149, the closest marker to the centromere on 18q, was uninformative. To define the breakpoint on the short arm of chromosome 18 when both D18S40 and D18S852 were uninformative, a BAC genomic clone containing the marker D18S852 was identified by electronic PCR in NCBI (http://www.ncbi.nlm.nih.gov) and ordered from BACPAC Resources (Buffalo, NY). DNA from this clone, RP11–808F20, was isolated with the Qiagen plasmid maxi kit (Valencia, CA) and also used as a probe for FISH.

Fresh metaphase spreads were baked for 4 hours at 65°C. The chromosomes were denatured for 2 minutes in 70% formaldehyde, 2× SSC (pH 7.0), dehydrated through an ethanol series, and dried. The probes were labeled with biotin-14-dATP by nick translation using a BioNick kit (Gibco BRL, Rockville, MD). The hybridization solution for each slide contained 40 ng labeled probe and 10 μg human Cot-1 DNA. After the DNA was denatured for 5 minutes at 70°C, the probes were added to the slides and were incubated overnight at 37°C. Next day, the probes were fluorescently tagged using avidin-fluorescein isothiocyanate (avidin-FITC; Vector Laboratories, Burlingame, CA). Signal amplification was achieved using biotin-labeled antiavidin (Vector Laboratories), followed by avidin-FITC. The chromosomes were counterstained with DAPI and visualized on a Zeiss Axioscope microscope. Digital images were captured using an imaging system and Provision Software from Applied Imaging (Santa Clara, CA).

Statistical methods

One-way analysis of variance was used to compare mean differences in parental age according to parental origin and deletion subgroups of interest, followed by a Tukey studentized range posthoc test to adjust for multiple comparisons20 (Table 1).

Table 1 Parental age comparisonsa

RESULTS

Deletion size and distribution

Figure 1 shows the breakpoint estimation using PCR based polymorphic markers. Of the total study population, 18 subjects had breakpoints between markers D18S852 and D18S1149 (72%), a map distance of 4 Mb, creating an apparent breakpoint cluster in the pericentromeric region on 18p. Current map distances on Figure 1 were obtained from the April 1, 2001, freeze of the sequence data obtained from The Human Genome Project Working Draft Web site at the University of California at Santa Cruz (http://genome.ucsc.edu).

Fig 1
figure 1

Molecular analysis of subjects with chromosome 18p deletions using polymorphic markers. Data from each participant is shown in a column under their study number. Closed circles indicate that the subject has two alleles for that marker. Open circles indicate that the subject has a single allele. Genotyping performed by fluorescence in situ hybridization is indicated by open or closed triangles. When the marker was uninformative, no mark is shown. The minimal region of the retained part of the chromosome is enclosed in a box.

Only seven subjects had breakpoints that were not located in the pericentromeric region of chromosome 18p. Patient 29 had a breakpoint between markers D18S458 and D18S1132, a distance of approximately 1 Mb, Patient 18 between markers D18S852 and D18S464 (5 Mb), Patient 17 between markers D18S453 and D18S976 (8 Mb), Patient 20 between markers D18S458 and D18S464 (4.5 Mb), Patient 22 between markers D18S464 and D18S1154 (7 Mb), and Patient 24 between markers D18S71 and D18S1116 (1 Mb). There was no specific pattern to the distribution of breakpoints in these individuals.

Parental origin

The maternal/paternal origin ratio for the entire group was 13:12, approximately 50:50. To determine whether parental origin differences were related to breakpoint location, parental origin ratios were compared between two groups: those with breakpoints in the pericentromeric region of 18 versus those not in the pericentromeric region. No significant difference between the groups was evident. In the first category, 10 deletions were of maternal origin and 8 of paternal origin; for those not in the pericentromeric group, 3 were maternal and 4 paternal.

To determine whether advanced parental age might be a causative factor in the 18p− syndrome, the mean differences in parental age at conception were assessed according to deletion and parental origin subgroups using one-way analysis of variance followed by a Tukey studentized range posthoc test to adjust for multiple comparisons20 (Table 1). Comparison of mean maternal age scores between breakpoint cluster (31.6 years) and nonbreakpoint cluster (27.0 years) subgroups exhibited a statistically significant difference (P = 0.02). In contrast, comparison of mean paternal age scores between breakpoint cluster (31.7 years) and nonbreakpoint cluster (29.7 years) subgroups did not exhibit a statistically significant difference (P = 0.14). Examination of the post hoc analyses indicates that no statistically significant differences in either maternal or paternal age (P < 0.05) were exhibited according to parental origin subgroup within either the breakpoint cluster or the nonbreakpoint cluster subgroups.

DISCUSSION

The parental origin of a de novo chromosomal deletion is usually paternal. Examples of deletion syndromes with a strong paternal origin bias are Wolf-Hirschorn syndrome (4p-),21 cri-du-chat syndrome (5p-),9,22 and the 18q− syndrome.16 One exception is 11q−, otherwise known as Jacobsen syndrome. Similar to our findings in the 18p− syndrome, the parental origin ratios are approximately 50:50 and there is also a breakpoint cluster present.23 The hypothesis for the formation of the breakpoint cluster in Jacobsen syndrome is the expression of a folate-sensitive fragile site, FRA11B, located in 11q23.3.24 Michaelis et al.25 documented the relationship in 11q− between parental origin of the deletion and the location of the breakpoint. Most maternally derived deletions are caused by breakage at FRA11B, whereas most paternally derived deletions occur distal to the fragile site.

Based on these similarities, we first hypothesized that a fragile site might be located at or near 18p11.1. However, there is no documented fragile site on 18p, despite our findings of an apparent breakpoint cluster. In addition, unlike the 11q− syndrome, the evenly split parental origin ratio remained the same regardless of whether the chromosome break occurred at the putative breakpoint cluster or at a more distal location on the chromosome. No bias toward paternal origin was detected in those subjects that had breakpoints that were not in the pericentromeric region. However, our small sample size (N = 7) prevents the formation of any definitive conclusions.

Although there is no known fragile site on 18p near the centromere, recent studies emphasize the importance of normally methylated pericentromeric DNA as a prerequisite for proper chromosome segregation and stabilization. Undermethylated pericentromeric satellite DNA and chromosomal abnormalities are found in the lymphocytes of patients with ICF, a genetic disease diagnosed by the combination of immunodeficiency, centromeric instability, and facial anomalies.26 DNA hypomethylation is also strongly correlated with chromosomal instability in human cancers.27 Certain polymorphisms in genes involved in folate metabolism and undermethylation of pericentromeric heterochromatin have been implicated as additional maternal risk factors for having a child with Down syndrome.28 In addition, the fragile site expressed in Jacobsen syndrome is folate-dependent.24 Folate-dependent fragile sites are caused by the expansion of CCG-repeats and the hypermethylation of adjacent CpG islands. Deletion breakpoints of paternal origin at more distal locations in Jacobsen syndrome have also been shown to contain CCG-repeats.29 Given these data, abnormal methylation of pericentromeric DNA in oogenesis or spermatogenesis, followed by breakage and the de novo addition or capture of a telomere,30 could explain the occurrence of the breakpoint cluster on 18p. Our statistical analysis of parental ages suggests that advanced maternal age may also be a contributing factor to the occurrence of pericentromeric 18p deletions.

The common distribution of breakpoints and the approximately equal parental origin ratios in our study population are also consistent with a mechanism of unequal crossing over between homologous chromosomes in meiosis I, resulting in monosomy 18p.31 Unequal recombination is the model proposed for some genetic syndromes caused by interstitial deletions, such as Williams syndrome32 and DiGeorge syndrome/VCFS.33 In most interstitial deletion syndromes, there is a common breakpoint region, a common deletion size, and an equal probability that the deletion is derived from either the paternal or the maternal chromosome.31 Interestingly, the marker order on the short arm of chromosome 18 in the genetic linkage map of the baboon (Papio hamadryas) genome is inverted in comparison with that of the human linkage map,34 suggesting that sequences in the pericentromeric region of 18p may be able to either serve as telomeres or as templates for telomerase, or have done so at some point in their evolutionary history. Whether any of the cytogenetically defined terminal deletions in our study population are cryptic rearrangements or actually interstitial deletions that have retained the original telomeres, will be addressed in future experiments.

As a result of the current study, we obtained data that clearly demonstrates the presence of a breakpoint cluster on 18p. Although we realize that some designated breakpoint clusters in other syndromes encompass smaller regions than 4 Mb, the distance could be narrowed when the fine mapping of this region is completed. The common breakpoint distribution that we found in our study population is in sharp contrast to that of other terminal deletion syndromes, including monosomy 1p3635 and particularly the 18q− syndrome,16 in which every individual appears to have a unique breakpoint. The parental origin of the 18p deletions appears to be equally distributed, half maternally derived and half paternally derived. Interestingly, in studies of other terminal deletion syndromes, all but one describes preferential loss of the paternal chromosomes.9,16,21,22 The one exception to this preferential distribution is the 11q− syndrome, also known as Jacobsen syndrome, which showed equal maternal and paternal distribution of chromosomal loss at a fragile site.23 Thus, both the breakpoint cluster and the parent-of-origin distribution support the presence of a hot spot for chromosomal breakage in the 18p− syndrome. Statistical analyses of average parental ages document an advanced maternal age bias for deletion breakpoints occurring in the pericentromeric region of 18p.

Further studies are needed to map the breakpoint region(s) in greater detail and to identify possible mechanisms for breakage. Also, clinical studies of the patients in this study have been initiated for the purpose of genotype/phenotype mapping. The detailed molecular analyses already performed should assist in elucidating the pathogenesis of the clinical manifestations and identifying critical regions and genes that are responsible for the 18p− phenotype.